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Methylmercury (MeHg), an environmental toxicant primarily found in ﬁsh and seafood, poses a dilemma to both consumers
and regulatory authorities, given the nutritional beneﬁts of ﬁsh consumption versus the possible adverse neurological damage.
Several studies have shown that MeHg toxicity is inﬂuenced by a number of biochemical factors, such as glutathione (GSH), fatty
acids, vitamins, and essential elements, but the cellular mechanisms underlying these complex interactions have not yet been fully
elucidated. The objective of this paper is to outline the cellular response to dietary nutrients, as well as to describe the neurotoxic
exposures to MeHg. In order to determine the cellular mechanism(s) of toxicity, the eﬀect of pretreatment with biochemical
factors (e.g., N-acetyl cysteine, (NAC); diethyl maleate, (DEM); docosahexaenoic acid, (DHA); selenomethionine, SeM; Trolox)
andMeHgtreatmentonintercellularantioxidantstatus,MeHgcontent,andotherendpointswasevaluated.Thispaperemphasizes
that the protection against oxidative stress oﬀered by these biochemical factors is among one of the major mechanisms responsible
forconferringneuroprotection.Itisthereforecriticaltoascertainthecellularmechanismsassociatedwithvariousdietarynutrients
as well as to determine the potential eﬀects of neurotoxic exposures for accurately assessing the risks and beneﬁts associated with
ﬁsh consumption.
1.Introduction
Methylmercury (MeHg) is a ubiquitous environmental
toxicant [1]. Several catastrophic epidemics resulting from
the consumption of food contaminated by MeHg have
highlighted the potentially disastrous eﬀects of MeHg on
living organisms. Important examples include outbreaks in
Minamata [2], Niigata [3], and Iraq [4]. MeHg is a potent
neurotoxicant which aﬀects both the developing and mature
CNS [5, 6]. In infants, MeHg causes widespread and diﬀuse
damage,whereasfocaldamageiscausedintheadultbrain.In
adults, chronic MeHg poisoning results in the degeneration
of the sensory cerebral cortex and the cerebellum, thereby
leading to severe neurological disturbances, such as cerebel-
lar ataxia and paresthesia, sensory and speech impairment,
and the constriction of the visual ﬁeld [4, 7, 8]. The patho-
logical changes involve general neuronal degeneration with
gliosis in the calcarine, and precentral and postcentral areas
of the cerebral cortex, as well as the loss of granular cells in
the cerebellar cortex [9]. In biological systems, MeHg exists
only at a very low concentration as a free, unbound cation
[10] which can bind to sulfhydryl groups (-SH) of amino
acids with a very high aﬃnity (log K in the order of 15–
23) [10]. This aﬃnity of Hg for sulphur and -SH groups
is a major factor underlying the biochemical properties of
MeHg, which, consequently, leads to its interference with the
enzyme activities of several cellular targets.
In the marine ecosphere, MeHg is sustained [11, 12] and,
afterbioaccumulation,isintroducedintothehumanpopula-
tion through the dietary intake of ﬁsh and seafood products.
[13–15]. MeHg toxicity due to the consumption of adul-
terated ﬁsh represents a major public health issue. Greater2 Journal of Toxicology
ﬁsh consumption in many cases is paralleled by increased
MeHg intake [16]; however, conversely, lower maternal
seafood intake has also been associated with higher risk
for a suboptimal developmental outcome [17]. According
to the Avon Longitudinal Study of Parents and Children
(ALSPAC),theauthorsreportedthatmaternalseafoodintake
during pregnancy of less than 340g per week was associated
with an increased likelihood for their children to fall into
the lowest quartile for verbal intelligence quotient (IQ)
when compared with mothers who consumed more than
340g of seafood per week. Though Hg consumption was
not assessed in this study, it is reasonable to assume that
greater ﬁsh consumption was paralleled by increased MeHg
intake. Moreover, several discrepancies in health outcomes
in ﬁsh-eating populations have been reported, such as
neurodevelopmental impairments in New Zealand [18–20]
and the Faroe Islands [21, 22], as opposed to the beneﬁcial
eﬀects noted in Canada [23], the Seychelles [24, 25], Peru
[26], and the United States [17, 27–30]. Additionally, labo-
ratory studies have also shown that dietary factors, such as
selenium, cysteine, protein, fat, ﬁber, and vitamin contents
can modulate the toxicity and excretion of mercury [31, 32].
Ap r e v i o u ss t u d y[ 33] has also shown a signiﬁcantly higher
rate of fecal excretion as well as a lower degree of MeHg
accumulationinthebrainsofratsfednaturallycontaminated
ﬁsh as compared to rats fed ﬁsh containing chemically added
MeHg. The above-mentioned studies indicate that, in addi-
tion to intrinsic, genetic factors, the phenotypic responses to
MeHgexposuremayultimatelydependonanumberofcom-
plex interactions within biological systems involving both
mercuryandvariousdietaryfactors.Itisthereforeimportant
to study the eﬀect(s) of confounding dietary factors that
occur when ﬁsh is consumed on MeHg distribution and
neurotoxicity. In this respect, it must be noted that diﬀerent
typesofﬁshaccumulatediﬀerentconcentrationsofnutrients
and contaminants [34–36]. Therefore it is of considerable
interest to determine how each component acts individually
(as well as with others) and inﬂuences the potential risk from
MeHg exposure. These cellular and molecular mechanisms
of MeHg action, as well as the underlying processes of its
interaction with dietary components have yet to be deﬁned,
especially in speciﬁc central nervous system (CNS) targets.
Accordingly, this paper focuses on studies directed toward
estimating the eﬀect(s) of dietary modiﬁers on MeHg neu-
rotoxicity, potentially providing information about critical
cellular mechanisms responsible for conferring neuroprotec-
tion from a diet that includes MeHg-contaminated ﬁsh.
2. MeHg-InducedOxidativeEffects:
Reactive Oxygen Species (ROS) Generation
andGlutathione(GSH)Depletion
The disruption of redox cellular homeostasis by an excess
of ROS formation, which leads to cumulative oxidative
stress appears to play a key role in the in vivo pathological
process of MeHg intoxication [37–42]. Conversely, several
studies have demonstrated the partial amelioration of MeHg
toxicity in the presence of antioxidants by the inhibition of
ROS generation [40, 43, 44]. Although the critical role of
oxidative stress in the pathogenesis of MeHg cytotoxicity has
been clariﬁed, the molecular mechanisms underlying MeHg-
mediatedoxidativestresshavenotyetbeenfullyelucidated.A
major source of MeHg-induced increases in ROS generation
may be the mitochondrial electron transport chain. The
damaged mitochondrion increases oxidative stress, leading
to a decrease in defense mechanisms, such as reduced GSH
content, which represents one of the principal endogenous
antioxidants. In addition, binding to GSH is reported to be
responsible for the excretion of MeHg. Therefore, decreased
GSH levels usually parallel increased oxidative stress due
to MeHg exposure [45–49]. However, two epidemiological
studies associating oxidative stress and MeHg exposure [50,
51]haveshownbothanincreaseandadecreaseinGSHlevels
with increased total Hg levels. This suggests that MeHg can
increase ROS which may either inhibit GSH levels or initiate
an adaptive response to oxidative stress by increasing GSH
levels. Moreover, studies of human populations, although of
direct interest, cannot be controlled for multiple confound-
ing variables. This obstacle can be overcome by conducting
studies on laboratory animals; such investigations can iden-
tify the mechanisms of action by which neurotoxicants and
neuroprotectants interact.
3. Role of GSH Modulators on
MeHg-InducedNeurotoxicity
Upregulation [52], or the induction of an increased synthesis
of GSH [45], has been reported to provide neuroprotection
against MeHg-induced neurotoxicity. A similar alleviation
in MeHg-induced cytotoxicity and oxidative stress has been
reported with N-acetyl cysteine (NAC) supplementation [39,
53–55]. The mechanisms involved in protection aﬀorded by
NAC include increased intracellular GSH [54, 55]a sw e l l
as a transient increase in the urinary excretion of MeHg,
which was shown to cause a decrease in the level of MeHg in
both the adult brain and the fetus [53, 56]. In addition, the
increasedamountofGSHincortical,ascomparedtocerebel-
lar, astrocytes has been reported to account for the increased
MeHg-inducedROSproductionincerebellarastrocytes[55].
Conversely, the depletion of intracellular GSH with
diethyl maleate (DEM) has been reported to increase cell-
associated MeHg and MeHg-induced ROS [48, 54, 55]. The
underlying mechanism of this process involves the conju-
gation of free sulfhydryl groups of GSH with DEM, which
results in the distinct depletion of GSH. Also, gestational
exposure to MeHg has been reported to cause the dose-
dependent inhibition of cerebral GSH levels, an outcome
which could be correlated with increased lipid peroxidation
in the pup brain [57]. These biochemical alterations were
found to endure even after Hg tissue levels decreased, thus
indicating permanent functional deﬁcits observed after pre-
natal MeHg exposure as well as an additional molecular
mechanism by which MeHg induces prooxidative damage in
the developing CNS.
In summary, changes in intracellular MeHg content with
GSH modulation provide an explanation for the increasedJournal of Toxicology 3
susceptibility of certain cell types towards MeHg-induced
oxidative stress [54, 55].
4. Role of DHAin Modulating
MeHg-InducedNeurotoxicity
DHA cis-4,7,10,13,16,19-docosahexaenoic acid, is one of the
most abundant polyunsaturated fatty acids (PUFA) in the
phospholipid fractions of the mammalian brain [58, 59].
Both seafood and breast milk serve as major dietary routes
of MeHg [60, 61] and DHA [62–65]. The ability of DHA
to aﬀect ROS is controversial, as several contrasting studies
have documented the ability of DHA to decrease the level
of lipid peroxide [66–68] and to cause free-radical-mediated
peroxidation in the brain [69–71]. DHA have been reported
to modulate MeHg toxicity [33, 72–74]. These studies have
demonstrated the beneﬁcial eﬀects of DHA on using a DHA-
enriched diet against MeHg-induced decreases in serum
albumin levels, changes in mitochondrial membrane poten-
tial, and developmental defects. However, other contradic-
tory studies have reported no protection against MeHg-
induced behavioral defects [75, 76]. It is therefore important
toidentifythebiochemicalmechanismsinvolvedintheDHA
protection against MeHg neurotoxicity.
Kaur and colleagues [77, 78] demonstrated that pretreat-
ment with DHA was associated with reduced cell-associated
MeHg in neuronal cell lines and primary cells. In addition,
decreased ROS and unchanged GSH levels were found in
primary cultures, whereas increased ROS and GSH depletion
werefoundinC6cells[77,78].Thesediﬀerenceswithrespect
to the eﬀect of DHA on oxidative stress could be due to the
fact that the growth of cancerous cells is inhibited by DHA
as compared to noncancerous cell types [71, 79]. Indeed,
another recent study has shown that ﬁsh oil oﬀers signiﬁcant
DNA protection as well as anti-inﬂammatory eﬀects in the
absence of changes in GSH levels [50]. These observations
strongly suggest that DHA may neuroprotect against MeHg-
induced ROS generation even in the absence of signiﬁcant
changes in GSH levels.
5. Role of Selenomethionine inModulating
MeHg-InducedNeurotoxicity
Selenium (Se) is an essential trace element known to
accumulate in signiﬁcant amounts in numerous species of
seafood [80, 81]. The majority of Se in ﬁsh is in the organic
form, selenomethionine (SeM) [82, 83], and is more bio-
available than are inorganic forms [84]. Selenium has also
been detected in human milk [85]. The modulating eﬀect
of Se on MeHg toxicity was discovered when researchers
observedthatmarinemammalscouldaccumulateexception-
ally high concentrations of Hg and Se compounds without
displaying obvious symptoms of intoxication [86, 87]. Sev-
eral subsequent studies later conﬁrmed that the toxic eﬀects
of both organic and inorganic Hg were prevented by Se com-
pounds [88–92]. Treatment with diﬀerent Se compounds
has been shown to eﬀectively protect cells against diﬀerent
toxic eﬀects induced by MeHg exposure, such as cytotoxicity,
fetotoxicity, neurotoxicity, and developmental and neurobe-
havioral toxicity [93–97]. In addition, Se deﬁciency has been
shown to potentiate the adverse eﬀects of MeHg toxicity in
rodents [98, 99].
With regard to epidemiological studies and Se content, it
is important to note that Faroe Islanders, by virtue of a whale
meat diet, are generally exposed to MeHg levels that are in
excess of Se levels [100], whereas the Seychellois are largely
ocean ﬁsh consumers, and Se molar concentrations tend to
greatly exceed MeHg concentrations in this seafood source
[101]. In addition, the dietary Se status in the New Zealand
populationwasextremelypooratthetimeofthestudy[102].
This distinction could be one explanation for the diﬀerent
eﬀects noted in these studies, although additional evidence
is needed to support this hypothesis [103]. Therefore, devel-
oping a better understanding of the mechanisms associated
withtheinteractionofMeHgandSeisofparticularnecessity.
Severalstudieshaveindicatedthatthemechanismunder-
lying Se’s ability to ameliorate MeHg toxicity is related to an
antioxidant eﬀect [104–108], which includes the forma-
tion of GSH [109], higher glutathione peroxidase (GPx)
activity [85], increased selenoprotein levels [110–112], and
the reduction of organic hydroperoxides [113–115]. Addi-
tionally, studies have shown that binding of MeHg [116,
117] and the formation of a highly stable organic MeHg-
selenocysteine complex [98] also inﬂuence the accumulation
ofMeHgintissues[118–121]andtheuptakeofMeHgincells
[114, 122–124]. Furthermore, Se is known to enhance the
excretion of MeHg [56, 125], and a recent study has shown
[126] that SeM can demethylate MeHg under physiologically
and environmentally relevant conditions. Hence, the inter-
active eﬀects between MeHg and SeM result in reduced cell-
associated MeHg and prooxidant response from MeHg.
6. Role of Trolox in Modulating
MeHg-InducedNeurotoxicity
Seafood serves as a source of vitamins, with estimates
ranging between 4.84 and 17.90μg vitamin E per gm of
ﬁsh [127], which makes this vitamin the most signiﬁcant
physiologicmembrane-associatedantioxidantavailablefrom
seafood. Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid), a water soluble analog of vitamin E [128],
serves as a better antioxidant than vitamin E [129, 130]
due to its improved access to the hydrophilic compartments
of the cells [131], as well as its stoichiometric properties
[132]. Trolox scavenges free radicals [59, 133–137] via the
H-donating groups [128, 138]. Treatment with Trolox has
been reported to protect against MeHg-induced cytotoxicity
[139], the decrease in mitochondrial electron transport
system enzyme activities, and the increase of mRNAs of
antioxidant enzymes [108, 140]. Trolox treatment has also
been shown to reverse ROS induction by MeHg in pri-
mary astrocyte cultures [44] and to prevent MeHg-induced
oxidative stress [141], where the modulating eﬀect of Trolox
on cellular ROS levels was not accompanied by changes in
c e l l u l a rM e H g ,G S H ,o rM T Ta c t i v i t y[ 141]. These ﬁndings
indicate that Trolox aﬀords protection against ROS by4 Journal of Toxicology
the direct quenching of free radicals and not by MeHg
chelation or by the induction of increased levels of GSH or
mitochondrialenzymes.Infact,ithasbeenpreviouslyshown
that in vivo protection with Trolox does not aﬀect intracellu-
lar GSH [142, 143]o rM e H gl e v e l s[ 140]. The recognition
of the protective eﬀects of Trolox and the identiﬁcation of
its mechanisms via in vitro models establish that vitamin-
dependent antioxidant defences are important factors in
speciﬁc cells for attenuating the neurotoxic eﬀects of a
MeHg-contaminated ﬁsh diet.
7. Discussion
Fish is not only an excellent nutritional source of protein,
vitamins, zinc, and other minerals, but it is also a source
of exposure to MeHg [144, 145]. One of the leading
controversies in the MeHg literature originates from advi-
sories concerning the consumption of ﬁsh [146]a n df r o m
uncertainties in documentation from various regulatory
agenciesregardingtheeﬀectsofMeHg.TheJointFAO/WHO
Expert Committee on Food Additives reported in 1978 that
“t h ef e t u sm a yb em o r es u s c e p t i b l et oM e H gt o x i c i t yt h a n
the adult”[ 147]. The United States White House in 1998
convened an international workshop where a variety of
possible uncertainties and confounders important to MeHg
toxicity evaluation were discussed. Their conclusions stated,
“Evenwhendietarystressesandco-exposurestootherchemicals
could plausibly enhance or alter risk, it was still deemed that
there are inadequate data on this subject to draw meaningful
c o n c l u s i o n sa tt h i st i m e ”[ 148]. Later, in 2000, the National
Academy of Sciences committee reported that, “60,000
children in the United States were at risk as a result of prenatal
exposure” [149]. However, no justiﬁcation or explanation for
that conclusion was provided [16, 150]. The issue that poses
a signiﬁcant dilemma for both consumers and regulatory
authorities is whether ﬁsh consumption should be encour-
aged for its nutritional beneﬁts to the developing brain or,
conversely, whether ﬁsh consumption should be discouraged
duetothepossibleadverseeﬀectsofMeHgonthedeveloping
CNS. This nutrition versus neurotoxicity controversy can
be addressed by estimating the eﬀects of dietary factors
on MeHg-induced toxicity as well as by determining the
mechanisms behind such eﬀects. A thorough assessment
of coexposure from dietary nutrients as well as neurotoxic
exposures would oﬀer valuable information for accurately
determining the risks and beneﬁts of ﬁsh consumption [151,
152].
This paper explores the mechanisms associated with
MeHg and dietary nutrients obtained from the consumption
of seafood. The toxicity of MeHg has been reported to be
caused by a reduction in the amount of intracellular GSH
[45, 46, 48], which leads to the augmentation of ROS
formation [37, 40–44, 153]. This paper investigates the
eﬀects of MeHg on oxidative stress and details the role
played by GSH in modifying these eﬀects. It also identiﬁes
the biochemical mechanisms underlying exposure to GSH,
DHA, Se, Trolox, and MeHg, where these modiﬁers have
been shown to eﬀectively decrease MeHg-induced ROS
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Figure 1: Eﬀect of diﬀerent modulators on MeHg-induced cellular
ROS in C6-glial and B35-neuronal cell lines. Results are expressed
as mean ± standard deviation (n = 8 replicates for each cell type in
two independent experiments). Superscript (a) indicates P < 0.05
for control versus each type of treatment; (b) indicates P < 0.05
for C6 versus B35 cell line for each type of treatment; (c) indicates
MeHg versus DHA/SeM or Trolox+MeHg-treated group. Values
represented the percentage of activity relative to control cells.
(Figure 1). In addition, it is important to note that the
interaction between these dietary nutrients may have an
eﬀect on overall toxicity. For example, the beneﬁts from
Se against MeHg toxicity can be inﬂuenced by the intake
of long-chain, polyunsaturated fatty acids (LCPUFAs) [65,
154]. It has also been shown that the shape of the dose-
eﬀect curve for Hg is dependent upon the co-exposure
of dietary components such as Se and vitamin E [145].
This paper, concludes that GSH, DHA, Se and Trolox are
strong confounders in the association of MeHg toxicity and
that the interaction between them may aﬀect the cellular
oxidative status. Thus, it is necessary to consider diﬀerent
confounders and the various mechanisms by which they
interact with Hg when investigating the potential beneﬁcial
eﬀects of ﬁsh consumption. Indeed, doing so would provide
valuable insight for developing a better understanding of
the beneﬁts and risks of ﬁsh consumption, acknowledging
both the proven beneﬁcial nutrients as well as the potentially
dangerous contaminants contained in this important food
source. Furthermore, such information would also assist
public health authorities as they seek to advise the populace
and as they undertake eﬀorts to formulate appropriate
dietary recommendations for consumers of ﬁsh and seafood
products.
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